Prescription-event monitoring (PEM) in 1996 - A method of non-interventional observational cohort pharmacovigilance

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue SUPPL. 3, 1997, Pages

  Mann, R D ^a   Wilton, L V ^a   Pearce, G L ^a   Mackay, F J ^a   Dunn, N R ^a  

^a Drug Safely Research Unit   (United Kingdom)

Author keywords

Cohort studies; Pharmacovigilance; Post marketing surveillance; Prescription event monitoring; Reasons for drug withdrawal

Indexed keywords

ACICLOVIR; AMLODIPINE; BETAXOLOL; BUSPIRONE; CIPROFLOXACIN; CISAPRIDE; DILTIAZEM; DOXAZOSIN; ETODOLAC; FAMOTIDINE; FINASTERIDE; FLUOXETINE; ISRADIPINE; ITRACONAZOLE; LAMOTRIGINE; LANSOPRAZOLE; MISOPROSTOL; NEDOCROMIL SODIUM; NICARDIPINE; OFLOXACIN; OMEPRAZOLE; PAROXETINE; PERINDOPRIL; SALMETEROL; SALMETEROL XINAFOATE; SERTRALINE; SUMATRIPTAN SUCCINATE; TERODILINE; UNINDEXED DRUG; VIGABATRIN; XAMOTEROL HYDROGEN FUMARATE;

COHORT ANALYSIS; CONFERENCE PAPER; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; MEDICAL RECORD; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0030782421     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199710)6:3+3.0.CO;2-F     Document Type: Conference Paper

References (6)

1. Rawlins, M. D. and Jefferys, D. B. United Kingdom product licence applications involving new active substances: their fate after appeals. British Journal of Clinical Pharmacology 1993; 35: 599-602.
2. Mann, R. D., Kubota, K., Pearce, G. and Wilton, L. Salmeterol: A study by prescription-event monitoring in a UK cohort of 15,407 patients. Journal of Clinical Epidemiology 1996; 49(2): 247-250.
3. Wilton, L. V., Pearce, G. L. and Mann, R. D. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. British Journal of Clinical Pharmacology 1996; 41: 277-284.
4. Wilton, L., Pearce, G., Edet, E., Freemantle, S., Stephens, M. D. B. and Mann, R. D. The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients. British Journal of Urology 1996; 78: 379-384.
5. Mann, R. D. Prescription-Event Monitoring: its role in ensuring new drug safety. Prescriber 1996; 7: 102-104.
6. BMA. Reporting Adverse Drug Reactions. A BMA policy document, 1996.